Found 0 matching trials
Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition PHASE1 A Two Way, Open Label, Single Dose, Cross Over, Experimental Evaluation of ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis PHASE1 Primary Objective:
* To characterize the pharmacodynamic profile of 2 trea...
Show More Location
Investigational Site Number 724001
Learn More & Join Trial
The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life N/A This prospective observational study aims to assess the health-related qual...
Show More Location
Renji Hospital, School of Medicine, Shanghai Jiaotong University
Learn More & Join Trial
A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735) PHASE4 This was a randomized, double-blind, parallel-group, multicenter study that...
Show More Location
Multiple Locations
Learn More & Join Trial
Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction EARLY_PHASE1 The objective of this study is to evaluate inhibition of mast cells and the...
Show More Location
Northwestern Medical Faculty Foundation
Learn More & Join Trial
Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria PHASE3 This is a multicenter, parallel group, randomized, double-blind, active con...
Show More Location
Univ of Cincinnati Medical Center
Learn More & Join Trial
Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182) PHASE4 This was a crossover study designed to see if patients with allergy symptom...
Show More Location
Multiple Locations
Learn More & Join Trial
Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection PHASE2 Chronic HBV patients will receive 9 doses of open-label ARC-520 once every ...
Show More Learn More & Join Trial
Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo PHASE2 A randomised, double-blind, placebo-controlled, 4-period incomplete block c...
Show More Location
GSK Investigational Site
Learn More & Join Trial
C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients. NA During the peak of the second COVID -19 wave, the hospitals were over-crowd...
Show More Learn More & Join Trial